Affymax(R) to Present at the Morgan Stanley Global and the Deutsche Bank 32nd Annual Healthcare Conferences.PALO ALTO Palo Alto, city, California Palo Alto (păl`ō ăl`tō), city (1990 pop. 55,900), Santa Clara co., W Calif.; inc. 1894. Although primarily residential, Palo Alto has aerospace, electronics, and advanced research industries. , Calif. -- Affymax, Inc. (Nasdaq: AFFY) today announced that Arlene M. Morris, the company's president and chief executive officer, will present at two upcoming healthcare conferences. Ms. Morris will present at the Morgan Stanley  To comply with Wikipedia's , the introduction of this article needs a complete rewrite. Global Healthcare Unplugged
Conference on Wednesday, May 2, 2007 at 10:15 a.m. Eastern Time in
Miami. The following day, Thursday, May 3, 2007, at 7:30 a.m. Eastern
Time, she will present at the Deutsche Bank Deutsche Bank AG (IPA: /'dɔɪ.tʃə/[1]) (ISIN: DE0005140008, NYSE: DB) (English: German Bank 32nd Annual Healthcare
Conference being held in Washington, D.C.
A live webcast of the presentation will be available on the Investors section of the company's website at www.affymax.com. A replay will also be available for 30 days following the presentation. About Affymax, Inc. Affymax, Inc. is a biopharmaceutical company developing novel peptide-based drugs to improve the treatment of serious and often life-threatening conditions. Affymax's lead product candidate, Hematide[TM], is currently in Phase 2 clinical trials phase 2 clinical trial Phase 2 study. See Phase study. for the treatment of anemia associated with chronic kidney disease Chronic kidney disease (CKD), also know as chronic renal disease, is a progressive loss of renal function over a period of months or years through five stages. Each stage is a progression through an abnormally low and progressively worse glomerular filtration rate, which is and cancer. For additional information, please visit www.affymax.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion